NCT07236879Recruiting
Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care
Effects of Artificial Intelligence-based Diabetic Retinopathy Screening on Timely Access to Treatment in Individuals With Diabetes
Source: ClinicalTrials.gov · Last updated 19 Nov 2025
Brief summary (registry, in English)
This is a clinical trial to evaluate the effects of universal screening for diabetic retinopathy (DR) and diabetic macular edema (DME) using artificial intelligence (AI) in the interpretation of fundus photographs obtained by trained nursing assistant using a portable fundus camera in a primary care setting, compared with images obtained by the same method, but interpreted by ophthalmologists.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 922 (estimated)
- First submitted
- 4 Jun 2025
- Start date
- 8 Aug 2024
- Primary completion date
- Aug 2026
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Diseases
- Diabetic eye disease
- NCT number
- NCT07236879
What you commit to
- Study type: Interventional
- Planned participants: 922
- From 8 Aug 2024 to the primary completion date, Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Any contraindication for pharmacological mydriasis (such as knowledge of having closed-angle glaucoma, pregnancy).
- Life expectancy less than 6 months
Who the study is looking for
- Adults (\> 18 years old) diagnosed with diabetes mellitus who agree to participate in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital de Clinicas de Porto Alegre Coordinator of this site? Confirm its status | Porto Alegre | Brazil | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.